UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Noncontrolling Interests in Operating Subsidiaries
Beginning balance (in shares) at Dec. 31, 2023		99,895,473
Beginning balance at Dec. 31, 2023	$ 589,609	$ 100	$ (98,258)	$ 906,153	$ (239,729)		$ 21,343
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	(189)				(186)		(3)
Other comprehensive income	0
Issuance of common stock for vesting of restricted stock units (in shares)		275,244
Shares withheld related to net share settlement of share-based awards (in shares)		(148,766)
Shares withheld related to net share settlement of share-based awards	(674)			(674)
Compensation expense for share-based awards	858			858
Ending balance (in shares) at Mar. 31, 2024		100,021,951
Ending balance at Mar. 31, 2024	589,604	$ 100	(98,258)	906,337	(239,915)		21,340
Beginning balance (in shares) at Dec. 31, 2024		96,048,999
Beginning balance at Dec. 31, 2024	552,619	$ 96	(118,542)	910,237	(275,786)	$ (1,180)	37,794
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	23,528				24,287		(759)
Other comprehensive income	662					662
Issuance of common stock for vesting of restricted stock units (in shares)		244,629
Shares withheld related to net share settlement of share-based awards (in shares)		(121,926)
Shares withheld related to net share settlement of share-based awards	(471)			(471)
Compensation expense for share-based awards	922			922
Ending balance (in shares) at Mar. 31, 2025		96,171,702
Ending balance at Mar. 31, 2025	$ 577,260	$ 96	$ (118,542)	$ 910,688	$ (251,499)	$ (518)	$ 37,035